H&F Corporate Investors X, Ltd.

In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 12, 2026), H&F Corporate Investors X, Ltd. reported 1 stock position worth $2.8 billion. Its top holding was Medline Class A (MDLN) at 100.0% of the portfolio. Compared with Q1 2026, it reduced 1. The biggest sale was Medline Class A (MDLN, shares −18%).

Most Recent 13F
Q2 2026
Location
San Francisco, CA
CIK
0001901930
Portfolio Value
$2.8B (Q2 2026)
SEC Filing
0001193125-26-345867 ↗ filed Aug 12, 2026

Holdings Value

0$1.0B$2.0B$3.0B$4.0B$5.0B Q1 2024: $0 Q1 2024 Q2 2024: $0 Q2 2024 Q3 2024: $0 Q3 2024 Q4 2024: $0 Q4 2024 Q1 2025: $0 Q1 2025 Q2 2025: $0 Q2 2025 Q3 2025: $0 Q3 2025 Q4 2025: $4.2B Q4 2025 Q1 2026: $3.8B Q1 2026 Q2 2026: $2.8B $2.8B Q2 2026

Holdings 1 stocks · $2.8B

MDLN Medline Inc. Class A 100.00% 70,874,326 $2.8B Reduce -18.0%

Portfolio Sells Q1 2026 → Q2 2026

MDLN Medline Inc. Class A Reduce -18.0% 100.00% 0.00

Portfolio Buys Q1 2026 → Q2 2026

None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 1$2.8BMDLN
Q1 2026 1$3.8BMDLN
Q4 2025 1$4.2BMDLN
Q3 2025 0$0
Q2 2025 0$0
Q1 2025 0$0
Q4 2024 0$0
Q3 2024 0$0
Q2 2024 0$0
Q1 2024 0$0